New Insights on MS: Understanding Energy Use in Your Body

Credibility

Interest

Key Takeaway

This study suggests a new way to see how MS may change over time by looking at how the body uses sugar for energy.

What They Found

The researchers used special scans called dynamic 18-F-FDG PET-MRI to look at how sugar moves in the bodies of people with MS. They found that those with secondary progressive MS (SPMS) seem to use more sugar than those with relapsing-remitting MS (RRMS). This is like noticing that a car going uphill needs more gas than a car on a flat road. The increased sugar use might mean that SPMS patients are experiencing different changes in their bodies. Overall, this method could help doctors understand MS better and see how it progresses over time.

Who Should Care and Why

MS patients and caregivers should pay attention because this study could lead to better ways to track how MS is changing. Just like a weather forecast helps you prepare for storms, understanding sugar use in MS might help doctors predict and manage symptoms. Caregivers can also learn how to support patients based on their progression. If this method becomes more common, it might change how treatments are decided, similar to how a GPS updates your route. Knowing more about how MS affects the body can help everyone involved feel more prepared and supported.

Important Considerations

This study had a small number of patients, which means we can't be sure these findings apply to everyone with MS. The researchers noted that further studies are needed to confirm if the increased sugar use is a reliable sign of disease progression. This is important because MS affects everyone differently, and more research will help make sure the findings are useful for all patients.

Categories:

MS Progression Early Research MS Diagnostics

Article Topics:

18 F-FDG kinetic analysisGlucose metabolismMultiple sclerosisSecondary progressive multiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News